Future Medicine Co., Ltd.
Clinical-stage biopharma developing novel synthetic drugs for inflammation, fibrosis, and oncology.
341170 | KO
Overview
Corporate Details
- ISIN(s):
- N/A
- LEI:
- Country:
- South Korea
- Address:
- 경기도 성남시 수정구 창업로 54 619호, 성남시
- Website:
- http://futuremedicine.co.kr/
- Sector:
- Manufacturing
- Industry:
- Manufacture of pharmaceuticals, medicinal chemical and botanical products
Description
Future Medicine Co., Ltd. is a clinical-stage biopharmaceutical company focused on the development of novel synthetic drugs. The company utilizes its proprietary FOCUSTM (Futuremedicine Origin Compound Universal System) platform, a technology based on nucleoside chemistry, to discover and regulate various in vivo targets. Its therapeutic pipeline addresses unmet medical needs in areas such as inflammation and fibrosis, including treatments for diabetic nephropathy and primary biliary cholangitis (PBC), as well as oncology.
This is a Fraction of the Available Data.
You're viewing a limited, static snapshot. Professionals use our API to get real-time, AI-ready data for Future Medicine Co., Ltd. and 9,000+ other companies.
Stop analyzing yesterday's news. Start building a real-time advantage.
Request Enterprise API AccessFilings
| Date | Filing | Language | Size | Actions |
|---|---|---|---|---|
| No filings match the current criteria. | ||||
Automate Your Workflow. Get a real-time feed of all Future Medicine Co., Ltd. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
No Financial Data Available
Standardized financial statements for the selected period are not yet available.
Need More History? Access decades of standardized financials for Future Medicine Co., Ltd. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
